Healthcare provider profile · identity verified

Gerald Michael Radlauer, M.D.

Internal Medicine · APPLE VALLEY, CA · NPI 1710956776

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	650	148
Atorvastatin Calcium	Atorvastatin Calcium	571	140
Nifedipine Er	Nifedipine	399	97
Albuterol Sulfate Hfa	Albuterol Sulfate	395	94
Alprazolam	Alprazolam	301	41
Metformin Hcl	Metformin Hcl	239	58
Omeprazole	Omeprazole	239	59
Simvastatin	Simvastatin	239	64
Levothyroxine Sodium	Levothyroxine Sodium	217	53
Losartan Potassium	Losartan Potassium	191	44
Acetaminophen-Codeine	Acetaminophen With Codeine	187	42
Atenolol	Atenolol	177	44
Amlodipine Besylate	Amlodipine Besylate	172	40
Azithromycin	Azithromycin	169	92
Metoprolol Tartrate	Metoprolol Tartrate	140	36
Trazodone Hcl	Trazodone Hcl	140	26
Hydralazine Hcl	Hydralazine Hcl	137	27
Gabapentin	Gabapentin	136	41
Tramadol Hcl	Tramadol Hcl	132	37
Rosuvastatin Calcium	Rosuvastatin Calcium	129	26
Lorazepam	Lorazepam	124	25
Baclofen	Baclofen	123	33
Pantoprazole Sodium	Pantoprazole Sodium	121	31
Lovastatin	Lovastatin	119	33
Prednisone	Prednisone	118	72
Carisoprodol	Carisoprodol	117	14
Clonidine Hcl	Clonidine Hcl	115	24
Donepezil Hcl	Donepezil Hcl	99	18
Furosemide	Furosemide	95	27
Tamsulosin Hcl	Tamsulosin Hcl	95	27
Alendronate Sodium	Alendronate Sodium	93	17
Metoprolol Succinate	Metoprolol Succinate	92	22
Fluticasone Propionate	Fluticasone Propionate	88	16
Zolpidem Tartrate	Zolpidem Tartrate	87	13
Eliquis	Apixaban	85	19
Clopidogrel	Clopidogrel Bisulfate	81	18
Glipizide	Glipizide	78	17
Citalopram Hbr	Citalopram Hydrobromide	77	16
Famotidine	Famotidine	76	19
Hydrochlorothiazide	Hydrochlorothiazide	75	20
Allopurinol	Allopurinol	71	12
Clonazepam	Clonazepam	63	suppressed
Fenofibrate	Fenofibrate	63	16
Meclizine Hcl	Meclizine Hcl	63	11
Potassium Chloride	Potassium Chloride	62	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	62	43
Diazepam	Diazepam	61	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	61	16
Montelukast Sodium	Montelukast Sodium	61	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	suppressed
Ondansetron Hcl	Ondansetron Hcl	58	17
Ozempic	Semaglutide	57	suppressed
Finasteride	Finasteride	56	15
Carvedilol	Carvedilol	54	12
Temazepam	Temazepam	53	suppressed
Labetalol Hcl	Labetalol Hcl	51	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	suppressed
Benazepril Hcl	Benazepril Hcl	43	12
Januvia	Sitagliptin Phosphate	43	suppressed
Promethazine Hcl	Promethazine Hcl	43	suppressed
Levetiracetam	Levetiracetam	42	suppressed
Jardiance	Empagliflozin	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Fluconazole	Fluconazole	39	25
Pioglitazone Hcl	Pioglitazone Hcl	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Clotrimazole	Clotrimazole	33	11
Lidocaine	Lidocaine	33	11
Minoxidil	Minoxidil	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	11
Triamcinolone Acetonide	Triamcinolone Acetonide	32	11
Xarelto	Rivaroxaban	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Topiramate	Topiramate	29	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	28	suppressed
Cephalexin	Cephalexin	28	22
Spironolactone	Spironolactone	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Clindamycin Hcl	Clindamycin Hcl	24	13
Enalapril Maleate	Enalapril Maleate	24	suppressed
Atrovent Hfa	Ipratropium Bromide	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	21	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Estradiol	Estradiol	21	suppressed
Levofloxacin	Levofloxacin	21	15
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Glimepiride	Glimepiride	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Lactulose	Lactulose	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Penicillin V Potassium	Penicillin V Potassium	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error